Helleborus (family Ranunculaceae) are well-known as ornamental plants, but less known for their therapeutic benefits. Over the past few years, Helleborus sp. has become a subject of interest for phytochemistry, pharmacology and other medical research areas. On the basis of their usefulness in traditional medicine, it was assumed that their biochemical profile could be a source of metabolites with the potential to overcome critical medical issues. There are studies involving natural extracts from these species which demonstrate that Helleborus plants are a valuable source of chemical compounds with great medical potential. Some phytochemicals produced by these species have been separated and identified a few decades ago: hellebrin, deglucohellebrin, 20-hydroxyecdysone and protoanemonin. Lately, many other active compounds have been reported and considered as promising remedies for severe diseases such as cancer, ulcer, diabetes and also for common medical problems such as toothache, eczema, low immunity and arthritis. This paper is an overview of the Helleborus genus focusing on some recentlydiscovered compounds and their potential for finding new drugs and useful biochemicals derived from these species.

No abstract

Plants may live and grow under suboptimal environmental conditions having certain biochemical and metabolic adaptations that facilitate their survival. Plant ''metabolic flexibility'' consists of the accomplishment of the same step in a metabolic pathway in a variety of different ways. Pyrophosphate which works as an energy donor when cellular ATP pools become diminished during stresses, alternative glycolytic reactions that bypass ATP-requiring steps, additional pathways for electron transport in plant mithocondria and the salvage pathways are some of the aspects related to ''energetic flexibility''. This key feature that plays an important role in plant acclimation to stress can be an important target for engineering enhanced stress tolerance in crop plants.

No abstract

No abstract